inetetamab
mAbexperimental
Clinical trial activity
15 trials · 11 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
9
Phase 3
1
Phase 4
4
Earliest trial started Sep 9, 2020 (NCT04681911)
Timeline
Indications
Mechanism of action
- Receptor protein-tyrosine kinase erbB-2ANTAGONIST
ERBB2 antagonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07182721 | Phase 2 | Sep 30, 2025 | Fudan University |
| NCT06818773 | Phase 4 | Feb 28, 2025 | Eastern Hepatobiliary Surgery Hospital |
| NCT06641544 | Phase 4 | Oct 17, 2024 | Sun Yat-Sen University |
| NCT06578299 | Phase 4 | Aug 30, 2024 | Fudan University |
| NCT05328440 | Phase 2 | May 20, 2022 | Henan Medical University, Hengrui Therapeutics, Inc. |
| NCT05291910 | Phase 4 | Mar 12, 2022 | Chinese Academy of Medical Sciences |
| NCT05823623 | Phase 2 | Feb 13, 2022 | Nanjing Medical University |
| NCT06234137 | N/A | Nov 27, 2021 | Wenzhou Medical University |
| NCT05749016 | Phase 2 | Nov 1, 2021 | Chinese Academy of Medical Sciences |
| NCT04963595 | Phase 2 | Aug 1, 2021 | Shandong University |
| NCT05016544 | Phase 1/Phase 2 (Phase 2) | Jul 28, 2021 | Sun Yat-Sen University |
| NCT04941885 | Phase 2 | Jun 25, 2021 | Sun Yat-Sen University |
| NCT06015100 | N/A | Feb 20, 2021 | Xi'an International Medical Center Hospital |
| NCT04736589 | Phase 3 | Feb 2, 2021 | Chinese Academy of Medical Sciences, Peking University |
| NCT04681911 | Phase 2 | Sep 9, 2020 | Sun Yat-Sen University |
Showing 15 of 15 trials
Page 1 / 1
Organizations
Research & Development (11)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Sun Yat-Sen University | Academic/Hospital | 4 | 4 | 2 | 2020 |
| Chinese Academy of Medical Sciences | Academic/Hospital | 3 | 3 | 3 | 2021 |
| Fudan University | Academic/Hospital | 2 | 2 | 2 | 2024 |
| Eastern Hepatobiliary Surgery Hospital | Academic/Hospital | 1 | 1 | 1 | 2025 |
| Henan Medical University | Academic/Hospital | 1 | 1 | 1 | 2022 |
| Hengrui Therapeutics, Inc. | For profit | 1 | 0 | 1 | 2022 |
| Nanjing Medical University | Academic/Hospital | 1 | 1 | 1 | 2022 |
| Peking University | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Shandong University | Academic/Hospital | 1 | 1 | 1 | 2021 |
| Wenzhou Medical University | Academic/Hospital | 1 | 1 | 1 | 2021 |
| Xi'an International Medical Center Hospital | Academic/Hospital | 1 | 1 | 1 | 2021 |
11 organizations
Page 1 / 1